Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04585490
Title Personalized Escalation of Consolidation Treatment Following Chemoradiotherapy and Immunotherapy in Stage III NSCLC in Stage III NSCLC
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Stanford University
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.